Get With the Guidelines-Stroke Registry (GWTG-Stroke)

January 27, 2025 updated by: American Heart Association
Get With The Guidelines-Stroke is a program for improving the quality of care for patients hospitalized with stroke by promoting consistent adherence to the latest evidence-based clinical practice guidelines.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

Get With The Guidelines®-Stroke is an in-hospital program for improving stroke care by promoting consistent adherence to the latest scientific treatment guidelines. Since its initiation in 2003, 2,637 hospitals have entered 3,892,063 patient records into the Get With The Guidelines-Stroke database. Numerous published studies demonstrate the program's success in achieving measurable patient outcome improvements.

Achievement measures tracked through the Get With The Guidelines®-Stroke:

  • IV rT-PA arrive by 3.5 hour, treat by 4.5hour
  • Early antithrombotics
  • VTE prophylaxis
  • Antithrombotics at or by discharge
  • Anticoagulation for Afib/Aflutter at or by discharge
  • Smoking cessation at or by discharge
  • Intensive Statin Therapy

Quality measures tracked through the Get With The Guidelines®-Stroke:

  • Dysphagia screen
  • Time to intravenous thrombolytic therapy-60 min
  • NIHSS reported
  • Stroke education at or by discharge
  • Rehabilitation considered at or by discharge
  • LDL Documented

Additional measures collected by Get With The Guidelines®-Stroke can be viewed at: https://www.heart.org/en/professional/quality-improvement/get-with-the-guidelines/get-with-the-guidelines-stroke/get-with-the-guidelines-stroke-patient-management-tool

Study Type

Observational

Enrollment (Estimated)

3892063

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 125 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

Patients with a diagnosis of Ischemic stroke or transient ischemic attack, Subarachnoid hemorrhage, Intracerebral hemorrhage, or Stroke not otherwise specified.

Description

Inclusion Criteria:

  • Patients presented with a diagnosis of Ischemic stroke or transient ischemic attack, Subarachnoid hemorrhage, Intracerebral hemorrhage, or Stroke not otherwise specified to the hosptials.

Exclusion Criteria:

  • Patients who do not have a diagnosis of Ischemic stroke or transient ischemic attack, Subarachnoid hemorrhage, Intracerebral hemorrhage, or Stroke not otherwise specified.
  • Patients under age of 18

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
In-hospital mortality
Time Frame: 6 days - mean for length of hospitalization for Stroke patients
6 days - mean for length of hospitalization for Stroke patients
Modified Rankin Scale at Discharge
Time Frame: 6 days - mean for length of hospitalization for Stroke patients
Patients grouped by Modified Rankin Scale at discharge
6 days - mean for length of hospitalization for Stroke patients
Risk-Adjusted Mortality Ratio (for Ischemic-Only and Ischemic and Hemorrhagic models)
Time Frame: 30 days post discharge from hospital
A ratio comparing the actual in-hospital mortality rate to the risk-adjusted expected mortality rate.
30 days post discharge from hospital

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

American Heart Association

Investigators

  • Study Director: Javed Butler, MD, American Heart Association

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2003

Primary Completion (Estimated)

January 1, 2040

Study Completion (Estimated)

January 1, 2040

Study Registration Dates

First Submitted

February 23, 2016

First Submitted That Met QC Criteria

February 23, 2016

First Posted (Estimated)

February 26, 2016

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

January 27, 2025

Last Verified

January 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 001 (Buy Pharma Ecza Deposu San. Tic. Ltd.)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on GWTG Stroke program

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belgium

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe